The Net Margin of Marksans Pharma Ltd (MARKSANS.NS) is 14.51%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2025-03-31 | 14.51% |
| 2024-03-31 | 14.41% |
| 2023-03-31 | 14.38% |
| 2022-03-31 | 12.38% |
| 2021-03-31 | 17.14% |
| 2020-03-31 | 10.32% |
| 2019-03-31 | 7.65% |
| 2018-03-31 | 3.60% |
| 2017-03-31 | 1.15% |
| 2016-03-31 | 8.79% |